SANKYO PHARMA

Sankyo Company Limited

Application Filed: 1998-11-10

Trademark Application Details

Status

710

Dead/Cancelled

CANCELLED - SECTION 8

Research	OneLook Acronym Finder
Serial Number	75586071
Registration Number	2399082
Mark Drawing Code	1000: Typeset: Word(s)/letter(s)/number(s)
Cancellation Code	2
Domestic Representative	Ako-Toren
Attorney Name	David Toren
Attorney Docket Number	DT- 2839
Law Office Assigned	M60
Employee Name	RITTNER, HANNO I

Timeline

1998-11-10	Application Filed
2000-08-08	Published for Opposition
2000-10-31	Trademark Registered
2006-08-10	Location: SCANNING ON DEMAND
2007-08-04	Cancelled
2007-08-04	Status: Dead/Cancelled
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Sankyo Company Limited
Address	5-1, Nihonbashi Honcho 3-chome, Chuo-ku Tokyo JP
Legal Entity Type	Corporation
Legal Entity State	JP

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Katrin Lewertoff
Sidley Austin LLP
787 Seventh Avenue
New York NY 10019

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis; estrogen and progesterone used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria 'vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, antiparkinsonism drugs, minor tranquilizers, and antianxiety agents

Type Code

Type

GS0051

Central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis; estrogen and progesterone used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria 'vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, antiparkinsonism drugs, minor tranquilizers, and antianxiety agents

Trademark Filing History

Description	Date	Event Coding
ASSIGNED TO EXAMINER	1999-05-28	1 DOCK D:Assigned to Examiner
NON-FINAL ACTION MAILED	1999-06-07	2 CNRT F:First Action
CORRESPONDENCE RECEIVED IN LAW OFFICE	1999-08-11	3 CRFA I:Incoming Correspondence
Sec. 1(B) CLAIM DELETED	2000-03-29	4 1.BD I:Incoming Correspondence
ASSIGNED TO EXAMINER	2000-03-30	5 DOCK D:Assigned to Examiner
CORRESPONDENCE RECEIVED IN LAW OFFICE	1999-12-13	6 CRFA I:Incoming Correspondence
EXAMINER'S AMENDMENT MAILED	2000-04-07	7 CNEA F:First Action
APPROVED FOR PUB - PRINCIPAL REGISTER	2000-04-13	8 CNSA O:Outgoing Correspondence
NOTICE OF PUBLICATION	2000-07-07	9 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2000-08-08	10 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER	2000-10-31	11 R.PR A:Allowance for Publication
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2003-03-10	12 TCCA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2006-07-06	13 TCCA I:Incoming Correspondence
CASE FILE IN TICRS	2006-08-10	14 CFIT O:Outgoing Correspondence
CANCELLED SEC. 8 (6-YR)	2007-08-04	15 C8.. O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.